Consistently, the NUP214-ABL1 fusion protein, which is a constitutively active form of ABL1, is found in 6% of patients with T-ALL and promotes proliferation and survival of T-lymphoblasts (34). Here, NUP214 is linked to acute lymphoblastic leukemia.